WHO ICTRP trial
A Study to Evaluate the Safety,Tolerance and Initial Efficacy of mRNA Vaccine in…
ChiCTR2300073495 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300073495 |
|---|---|
| Public title | A Study to Evaluate the Safety,Tolerance and Initial Efficacy of mRNA Vaccine in Patients With Advanced Hepatocellular Carcinoma |
| Scientific title | An Open, Single-center, Multiple-dose, Dose-increasing and Dose-expanding Clinical Study to Observe and Evaluate the Safety, Tolerance, Immunokinetics and Preliminary Effectiveness of ABOR2014 Injection (IPM511) in the Treatment of Advanced Hepatocellular Carcinoma |
| Primary sponsor | Peking Union Medical College Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Advanced hepatocellular carcinoma |
| Interventions | Single arm:ABOR2014 Injection(IPM511) |
| Registration date | Jul 12, 2023 |
| Target size | Single arm:48 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: